Roeland Johannes Middelbeek, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Obesity, Morbid | 3 | 2016 | 1204 | 0.720 |
Why?
|
Diabetes Mellitus, Type 1 | 4 | 2022 | 3336 | 0.700 |
Why?
|
Glucuronidase | 1 | 2021 | 207 | 0.690 |
Why?
|
Prediabetic State | 2 | 2022 | 493 | 0.630 |
Why?
|
Bariatric Surgery | 3 | 2017 | 940 | 0.610 |
Why?
|
Exercise | 9 | 2023 | 5611 | 0.540 |
Why?
|
Physical Conditioning, Animal | 6 | 2021 | 362 | 0.520 |
Why?
|
European Union | 1 | 2015 | 157 | 0.490 |
Why?
|
Adipose Tissue, White | 4 | 2023 | 345 | 0.470 |
Why?
|
Taxes | 1 | 2016 | 221 | 0.470 |
Why?
|
Endocrine System Diseases | 1 | 2015 | 248 | 0.440 |
Why?
|
Glucose | 6 | 2021 | 4391 | 0.430 |
Why?
|
Endocrine Disruptors | 1 | 2015 | 237 | 0.410 |
Why?
|
Blood Glucose | 6 | 2022 | 6249 | 0.400 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5724 | 0.380 |
Why?
|
Sexually Transmitted Diseases | 1 | 2016 | 622 | 0.360 |
Why?
|
Weight Loss | 4 | 2021 | 2604 | 0.360 |
Why?
|
Adipose Tissue, Brown | 4 | 2023 | 754 | 0.310 |
Why?
|
Metabolome | 1 | 2014 | 881 | 0.310 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2023 | 11695 | 0.290 |
Why?
|
Hypoglycemic Agents | 3 | 2022 | 2866 | 0.270 |
Why?
|
Telemedicine | 1 | 2023 | 2853 | 0.270 |
Why?
|
Cytokines | 1 | 2021 | 7317 | 0.270 |
Why?
|
Gastric Bypass | 1 | 2014 | 812 | 0.270 |
Why?
|
Cost of Illness | 1 | 2015 | 1852 | 0.260 |
Why?
|
Insulin | 4 | 2022 | 6575 | 0.260 |
Why?
|
Metformin | 1 | 2021 | 829 | 0.250 |
Why?
|
Adaptation, Physiological | 3 | 2023 | 1310 | 0.230 |
Why?
|
Pandemics | 2 | 2022 | 8328 | 0.230 |
Why?
|
Diabetic Retinopathy | 1 | 2022 | 1205 | 0.230 |
Why?
|
Lipids | 1 | 2014 | 3302 | 0.230 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2022 | 436 | 0.220 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3236 | 0.210 |
Why?
|
Environmental Exposure | 1 | 2015 | 4231 | 0.190 |
Why?
|
Hepatocyte Growth Factor | 1 | 2021 | 270 | 0.170 |
Why?
|
Motor Activity | 2 | 2023 | 2714 | 0.170 |
Why?
|
Quality of Life | 2 | 2021 | 12730 | 0.170 |
Why?
|
Adipokines | 2 | 2019 | 318 | 0.170 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2019 | 75 | 0.160 |
Why?
|
Superoxide Dismutase | 1 | 2021 | 596 | 0.160 |
Why?
|
Ecosystem | 1 | 2022 | 471 | 0.160 |
Why?
|
Chemokine CCL2 | 1 | 2021 | 617 | 0.160 |
Why?
|
Oleic Acids | 1 | 2018 | 70 | 0.160 |
Why?
|
Adipose Tissue | 3 | 2023 | 3278 | 0.130 |
Why?
|
Maryland | 1 | 2016 | 276 | 0.130 |
Why?
|
Mental Disorders | 1 | 2015 | 6587 | 0.130 |
Why?
|
Hypoglycemia | 1 | 2022 | 859 | 0.130 |
Why?
|
Muscle, Skeletal | 5 | 2022 | 4933 | 0.130 |
Why?
|
Cardiovascular Diseases | 3 | 2021 | 15108 | 0.130 |
Why?
|
Energy Metabolism | 2 | 2017 | 2896 | 0.120 |
Why?
|
Interleukin-6 | 2 | 2021 | 3199 | 0.110 |
Why?
|
Leptin | 1 | 2021 | 1593 | 0.110 |
Why?
|
Humans | 25 | 2023 | 742088 | 0.110 |
Why?
|
Mesenchymal Stem Cells | 1 | 2022 | 1625 | 0.100 |
Why?
|
Placenta | 1 | 2021 | 1694 | 0.100 |
Why?
|
Subcutaneous Fat | 1 | 2015 | 391 | 0.100 |
Why?
|
Body Composition | 1 | 2021 | 2400 | 0.100 |
Why?
|
Fatty Acids | 1 | 2019 | 1806 | 0.100 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 2283 | 0.090 |
Why?
|
Life Style | 3 | 2021 | 3824 | 0.090 |
Why?
|
Ethanol | 1 | 2016 | 1337 | 0.090 |
Why?
|
Adult | 10 | 2023 | 213712 | 0.080 |
Why?
|
Male | 15 | 2023 | 349538 | 0.080 |
Why?
|
Mice, Inbred C57BL | 6 | 2023 | 21821 | 0.080 |
Why?
|
Hemoglobin A | 1 | 2007 | 87 | 0.070 |
Why?
|
Oxygen | 1 | 2018 | 4169 | 0.070 |
Why?
|
Oxygen Consumption | 3 | 2018 | 1869 | 0.070 |
Why?
|
Postprandial Period | 1 | 2007 | 292 | 0.070 |
Why?
|
Muscle Contraction | 1 | 2010 | 1241 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5304 | 0.060 |
Why?
|
Mice | 10 | 2023 | 81045 | 0.060 |
Why?
|
Female | 11 | 2023 | 379592 | 0.060 |
Why?
|
AMP-Activated Protein Kinases | 2 | 2021 | 608 | 0.060 |
Why?
|
Insulin Resistance | 2 | 2017 | 3861 | 0.060 |
Why?
|
Obesity | 3 | 2023 | 12705 | 0.060 |
Why?
|
Acclimatization | 1 | 2023 | 103 | 0.050 |
Why?
|
Homeostasis | 1 | 2012 | 3335 | 0.050 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2023 | 265 | 0.050 |
Why?
|
Inguinal Canal | 1 | 2021 | 69 | 0.050 |
Why?
|
Insulin Infusion Systems | 1 | 2022 | 212 | 0.050 |
Why?
|
Fasting | 1 | 2007 | 1589 | 0.050 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2021 | 92 | 0.050 |
Why?
|
Cell Transdifferentiation | 1 | 2021 | 171 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2007 | 1780 | 0.040 |
Why?
|
Mixed Function Oxygenases | 1 | 2021 | 272 | 0.040 |
Why?
|
Animals | 10 | 2023 | 168561 | 0.040 |
Why?
|
Middle Aged | 5 | 2023 | 213127 | 0.040 |
Why?
|
Receptors, Calcitriol | 1 | 2021 | 350 | 0.040 |
Why?
|
Gastrointestinal Hormones | 1 | 2017 | 97 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2030 | 0.040 |
Why?
|
Body Mass Index | 1 | 2014 | 12695 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2021 | 14554 | 0.030 |
Why?
|
Cohort Studies | 2 | 2018 | 40450 | 0.030 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2017 | 402 | 0.030 |
Why?
|
Appetite | 1 | 2017 | 243 | 0.030 |
Why?
|
Bile Acids and Salts | 1 | 2017 | 353 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2021 | 19223 | 0.030 |
Why?
|
Vagus Nerve | 1 | 2017 | 437 | 0.030 |
Why?
|
Cold Temperature | 1 | 2018 | 774 | 0.030 |
Why?
|
Health | 1 | 2017 | 390 | 0.030 |
Why?
|
Hepatocytes | 1 | 2021 | 1209 | 0.030 |
Why?
|
Patient Education as Topic | 1 | 2022 | 2275 | 0.030 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2015 | 689 | 0.030 |
Why?
|
Sorbitol | 1 | 2010 | 59 | 0.020 |
Why?
|
Reward | 1 | 2017 | 940 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2021 | 2585 | 0.020 |
Why?
|
Cell Line | 2 | 2018 | 15994 | 0.020 |
Why?
|
Ion Channels | 1 | 2015 | 1056 | 0.020 |
Why?
|
Overweight | 1 | 2021 | 2366 | 0.020 |
Why?
|
Transcription Factors | 2 | 2023 | 12164 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1887 | 0.020 |
Why?
|
Energy Intake | 1 | 2017 | 2147 | 0.020 |
Why?
|
Self Report | 1 | 2020 | 3548 | 0.020 |
Why?
|
Myoblasts | 1 | 2010 | 238 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2015 | 995 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 4553 | 0.020 |
Why?
|
Adipocytes | 1 | 2015 | 1182 | 0.020 |
Why?
|
Intestines | 1 | 2017 | 1923 | 0.020 |
Why?
|
Young Adult | 1 | 2014 | 56350 | 0.020 |
Why?
|
Risk Factors | 2 | 2022 | 72145 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 625 | 0.020 |
Why?
|
Adolescent | 1 | 2014 | 85649 | 0.020 |
Why?
|
Biological Transport | 1 | 2010 | 2119 | 0.020 |
Why?
|
Liver | 1 | 2021 | 7470 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2017 | 3187 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2012 | 4771 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2010 | 3701 | 0.010 |
Why?
|
Homocysteine | 1 | 2006 | 647 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5180 | 0.010 |
Why?
|
Mitochondria | 1 | 2015 | 3520 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 7901 | 0.010 |
Why?
|
RNA Interference | 1 | 2010 | 2890 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 15194 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29087 | 0.010 |
Why?
|
Phosphorylation | 1 | 2010 | 8436 | 0.010 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2006 | 1573 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23387 | 0.010 |
Why?
|
Cholesterol | 1 | 2006 | 2895 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2006 | 2354 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 57683 | 0.010 |
Why?
|
Smoking | 1 | 2006 | 8969 | 0.010 |
Why?
|
Aged | 1 | 2018 | 162944 | 0.000 |
Why?
|